Winning Health Says AI-Native WiNEX Platform Drives Full-Scene Intelligence, 8 AI Products Launched in H1 2026
Winning Health disclosed at its 2026 interim results briefing that AI-related revenue now comes from two streams: the AI-native WiNEX platform, which has integrated AI models and agents to support full-scene intelligent transformation, and incremental AI products from its AI healthcare unit, with eight products launched in the first half of 2026 and contract orders significantly up from 2025. The company also noted a rise in standalone AI projects, with clients increasingly allocating dedicated budgets. Its most recognized AI products are MedMap and the AI intensive-care system.
At its 2026 interim results briefing, Winning Health disclosed that its AI-related revenue comprises two components. First, the AI-native WiNEX platform has fully integrated foundational capabilities such as AI models and intelligent agents, and is advancing a full-scene intelligent transformation. Second, the AI healthcare business unit's incremental AI products—eight of which were launched in the first half of 2026—have seen a notable increase in contract orders compared with 2025.
The company also observed a gradual rise in the number of standalone AI projects. Whereas AI initiatives were previously often embedded within larger projects, an increasing number of clients are now setting up dedicated budgets for them. At present, the AI products most recognized by customers are MedMap (medical case intelligence mapping) and the AI intensive-care system.